Description
DENV2 (strain Thailand/16681/1984) Envelope Protein, His Tag (MALS & SPR verified) | ENN-D5243-500ug| Gentaur Distribution US, UK & Europe
Dengue is a mosquito-borne viral disease widely spread all over the world transmitted by 4 serotypes of dengue virus (DENV). The symptoms range from mild dengue fever to dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) with high mortality. Currently, most of the studies on DENV vaccines emphasize on its envelope protein which is essential for viral attachment and fusion (i.e., Sanofi’s tetravalent dengue vaccine Dengvaxia). However, the vaccine of envelope protein still needs to be improved to maximize its efficiency on people never infected with DENV before, which requires more research to be conducted on the DENV envelope protein.
Source: DENV2 (strain Thailand/16681/1984) Envelope Protein, His Tag (ENN-D5243) is expressed from human 293 cells (HEK293). It contains AA Phe 115 - Thr 280 & Met 281 - Ser 677 (Accession # P29990).
Format: Powder.
Tag: N-10×His.
Expression System: HEK293.
Expression Region: Phe 115 - Thr 280 & Met 281 - Ser 677.
Conjugate: Unconjugated.
Molecular Weight: 65.0 kDa.
Characteristics: This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 65.0 kDa. The protein migrates as 60 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Purity: 90%.
Buffer: PBS, pH7.4.
Storage Conditions: -20℃.
Shipping Conditions: RT
